Stock PROGEN PROSTATYPE GENOMICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Prostatype Genomics AB

Equities

PROGEN

SE0014684569

Market Closed - Nasdaq Stockholm
Other stock markets
 16:24:16 14/05/2024 BST 		5-day change 1st Jan Change
0.044 SEK -13.73% Intraday chart for Prostatype Genomics AB +41.94% -53.68%
04-18 Prostatype Genomics Announces Very Strong Interim Results from Long-Term Follow-Up Study with Prostatype in Uppsala CI
04-17 Prostatype Genomics Updates on Significant Progress in the US Study with Prostatype® CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Prostatype Genomics publishes Annual Report for 2023
AQ
NOTICE OF ANNUAL GENERAL MEETING IN PROSTATYPE GENOMICS AB (PUBL)
AQ
Prostatype Genomics announces outcome of exercise of warrants of series 3 (TO3)
AQ
Prostatype Genomics announces very strong interim results from long-term follow-up study with Prostatype® in Uppsala
AQ
Prostatype Genomics updates on significant progress in the US study with Prostatype®
AQ
Prostatype Genomics announces strong positive final results from multicentre study with Prostatype® in Spain
AQ
The exercise period for Prostatype Genomic's warrants of series 3 begins today
AQ
Prostatype Genomics enters into collaboration with Professor E. David Crawford, MD, University of California San Diego, in preparation for the commercial launch of Prostatype® in the United States
AQ
Prostatype Genomics publishes newsletter on US progress and the long-term follow-up study in Uppsala
AQ
Prostatype Genomics' long-term study with Uppsala University Hospital will be presented at the AUA conference in the US in May 2024
AQ
Prostatype Genomics publishes year-end report for 2023
AQ
Prostatype Genomics receives CAP laboratory accreditation, achieves another milestone towards entering the US market
AQ
Prostatype Genomics acquires CLIA Certificate to facilitate rapid US market launch with a significantly stronger financial outlook
AQ
ResearchDx and Prostatype Genomics Inc. in CLIA-laboratory agreement for the US-market
AQ
Prostatype Genomics AB carries out a directed share issue to guarantors following completed rights issue
AQ
Prostatype Genomics AB: Rights issue registered and trading in paid subscription units ceases
AQ
Prostatype Genomics announces final outcome of the Rights Issue
AQ
Prostatype Genomics announces preliminary outcome of the Rights Issue
AQ
Long term follow up study at Akademiska University Hospital, Uppsala, to be presented at EAU-meeting, May 2024: Indicates new area of use for Prostatype®
AQ
Prostatype Genomics publishes monthly newsletter and its net sales for the third quarter of 2023
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PROGEN Stock
  4. News Prostatype Genomics AB
  5. Press Releases